Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

327 ARTÍCULOS , VIENDO DEL 31 AL 45

In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease

Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Doré V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):816-26. doi: 10.1007/s00259-013-2681-7. Epub 2014 Feb 11.

German adaptation of the Resources for Enhancing Alzheimer's Caregiver Health II: study protocol of a single-centred, randomised controlled trial

Heinrich S, Berwig M, Simon A, Jänichen J, Hallensleben N, Nickel W, Hinz A, Brähler E, Gertz HJ.

BMC Geriatr. 2014 Feb 12;14:21. doi: 10.1186/1471-2318-14-21.

A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects

Grimaldi LM, Zappalà G, Iemolo F, Castellano AE, Ruggieri S, Bruno G, Paolillo A.

J Neuroinflammation. 2014 Feb 13;11:30. doi: 10.1186/1742-2094-11-30.

Cholinesterase-inhibitor Associated Mania: A Case Report and Literature Review

Jalal H, Ganesh A, Lau R, Lysack J, Ismail Z.

Can J Neurol Sci. 2014 Mar;41(2):278-80. doi: 10.1017/s0317167100016735.

Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis

Alva G, Isaacson R, Sadowsky C, Grossberg G, Meng X, Somogyi M.

Int J Geriatr Psychiatry. 2014 Sep;29(9):920-7. doi: 10.1002/gps.4080. Epub 2014 Feb 18.

New York can be our nation's center for Alzheimer's research

Vann AS.

Am J Alzheimers Dis Other Demen. 2014 Sep;29(6):489-91. doi: 10.1177/1533317514523670. Epub 2014 Feb 18.

Item response theory analysis of cognitive tests in people with dementia: a systematic review

McGrory S, Doherty JM, Austin EJ, Starr JM, Shenkin SD.

BMC Psychiatry. 2014 Feb 19;14:47. doi: 10.1186/1471-244X-14-47.

Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease

Stefanova NA, Kozhevnikova OS, Vitovtov AO, Maksimova KY, Logvinov SV, Rudnitskaya EA, Korbolina EE, Muraleva NA, Kolosova NG.

Cell Cycle. 2014;13(6):898-909. doi: 10.4161/cc.28255. Epub 2014 Feb 17.

Ethics review as a catalyst for progress

Rosen AC, Ashford JW, Perry G.

J Alzheimers Dis. 2014;40(2):233-5. doi: 10.3233/JAD-132762.

Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease

Zhang N, Song X, Bartha R, Beyea S, D'Arcy R, Zhang Y, Rockwood K.

Curr Alzheimer Res. 2014 May;11(4):367-88. doi: 10.2174/1567205011666140302200312.

Cognitive behavioral group intervention for Alzheimer caregivers

Passoni S, Moroni L, Toraldo A, Mazzà MT, Bertolotti G, Vanacore N, Bottini G.

Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):275-82. doi: 10.1097/WAD.0000000000000033.

PET imaging of garbage protein in Alzheimer's disease: does it require reappraisal of brain PET analysis?

Goldman S.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):813-5. doi: 10.1007/s00259-014-2740-8.

Sustained 4-year cognitive and functional response in early Alzheimer's disease with pioglitazone

Read S, Wu P, Biscow M.

J Am Geriatr Soc. 2014 Mar;62(3):584-6. doi: 10.1111/jgs.12722.

Does the evidence say a 4-point change in ADAS-cog score is clinically significant?

Oremus M.

Alzheimers Dement. 2014 May;10(3):416-7. doi: 10.1016/j.jalz.2013.12.017. Epub 2014 Mar 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias